| Title |
Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome? |
| Creator |
John J. Chen; Clare L. Fraser |
| Affiliation |
Mayo Clinic (JJC), Rochester, Minnesota; and Save Sight Institute (CLF), Faculty of Health and Medicine, The University of Sydney, Sydney, Australia |
| Abstract |
Myelin oligodendrocyte glycoprotein (MOG-IgG) antibodies have been associated with a variety of demyelinating neurologic disorders, including optic neuritis. It remains unclear whether the presence of MOG-IgG represents a distinct syndrome or is simply a marker for central demyelination. Two experts, John J. Chen, MD, PhD, and Clare L. Fraser, MBBS, MMed, debate this topic. |
| Subject |
Autoantibodies; Demyelinating Autoimmune Diseases, CNS / diagnosis; Demyelinating Autoimmune Diseases, CNS / immunology; Humans; Myelin-Oligodendrocyte Glycoprotein / immunology; Syndrome |
| Date |
2019-09 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Publication Type |
Journal Article |
| Source |
Journal of Neuro-Ophthalmology, September 2019, Volume 39, Issue 3 |
| Collection |
Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/ |
| Publisher |
Lippincott, Williams & Wilkins |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
© North American Neuro-Ophthalmology Society |
| ARK |
ark:/87278/s62z6w0t |
| Setname |
ehsl_novel_jno |
| ID |
1595904 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s62z6w0t |
